Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 1, 1986Annals of Internal Medicine

Alternating Non-Cross-Resistant Combination Chemotherapy or MOPP in Stage IV Hodgkin's Disease

View Full Paper
Ask AI
Bookmark
Share

Authors

GBGianni BonadonnaUniversity of VeronaPVPinuccia ValagussaFondazione Michelangelo
Armando Santoro
Armando SantoroUniversità Cattolica del Sacro Cuore

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Bonadonna et al. (1986) studied this question.

synapsesocial.com/papers/6a7d77a6b920b2eb49775fb6https://doi.org/10.7326/0003-4819-104-6-739
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Second acute leukemia and other malignancies following treatment for Hodgkin's disease.1986 · 314 citations
  2. 2BCVPP Chemotherapy for Advanced Hodgkin's Disease: Evidence for Greater Duration of Complete Remission, Greater Survival, and Less Toxicity Than with a MOPP Regimen1984 · 77 citations
  3. 3Nonparametric Estimation from Incomplete Observations1958 · 39,539 citations
  4. 4Alternating Drug Combinations in the Treatment of Advanced Hodgkin's Disease1982 · 214 citations
  5. 5Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP1975 · 759 citations